Cardiovascular Diseases Clinical Trial
Official title:
Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases
The purpose of this study is to assess the effect of optimized oil (enriched with
micronutriments) on the prevention on cardiovascular diseases.
Randomised crossover dietary intervention study:
The main objective of the clinical study is to investigate the effect of the consumption of
an "optimized" rapeseed oil on the lipid metabolism of volunteers as compared with the
consumption of a "reference" oil.
Post prandial study:
The second objective of the clinical study is to investigate the effect of the consumption
of an "optimized" rapeseed oil on the biomarkers of oxidative stress during post prandial
period as compared with the consumption of a "reference" oil.
For both studies, sedentary men between 30 and 65 years of age, with a BMI between 25 and
30, without cardiovascular disorders, will be selected.
Randomised crossover dietary intervention study:
Sixty volunteers will be randomised into 2 groups of 30. The study will last 12weeks. The
first 3 weeks will be an adaptation period or "run in". Volunteers will have every day20 g
of the reference rapeseed oil and 20 g of the reference oil-based rapeseed margarine.
Subsequently, the two groups will follow 2 dietary intervention periods of 3 weeks during
which the volunteers will have alternatively either the reference oil/margarine or the
optimized oil/margarine. Three weeks of "wash out" will separate the two dietary
interventions of the cross over design trial.
Cardiovascular risk and oxidative stress biomarkers will be assessed in plasma at week 0, 3,
6, 9 and 12.
Volunteers will alsoperform dietary surveys at the week 3, 6, 9 and 12.
Post prandial study:
16 volunteers will be cast lots among the 60 volunteers. They will be randomised into 2
groups of 8. The first kinetic study will be done on week 3. 8 subjects will take 66 g of
reference oil and 8 subjects will take 66 g of the optimized oil. 5 blood samples (20 mL
each) will be taken.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|